Bolt Biotherapeutics

(NASDAQ) BOLT

Current Price$3.95

Market Cap$8.21M

Since IPO (2021)-99%

5 Year-99%

1 Year-26%

1 Month-19%

Bolt Biotherapeutics Financials at a Glance

Market Cap

$8.21M

Revenue (TTM)

$6.50M

Net Income (TTM)

-$29.58M

EPS (TTM)

-$16.34

P/E Ratio

-0.26

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$3.95

Volume

1,908

Open

$4.18

Price

$3.95

Volume

1,908

Open

$4.18

Previous Close

$3.95

Daily Range

$3.93 - $4.18

52-Week Range

$3.75 - $7.20

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$3.95

Volume

1,908

Open

$4.18

Previous Close

$3.95

Daily Range

$3.93 - $4.18

52-Week Range

$3.75 - $7.20

Estimated Earnings Date

Aug 13, 2026

BOLT News

Bolt Revenue Jumps 39 Percent in Q2

Motley Fool Markets TeamAug 14, 2025

Why Bolt Biotherapeutics Stock Crashed Today

Keith SpeightsDec 6, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bolt Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

William P. Quinn, MBA

Website

www.boltbio.com

Headquarters

Redwood City, CA 94063, US

BOLT Financials

Key Financial Metrics (TTM)

Gross Margin

96.88%

Operating Margin

-463.44%

Net Income Margin

-455.15%

Return on Equity

-100.90%

Return on Capital

-70.02%

Return on Assets

-61.59%

Earnings Yield

-3.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.21M

Shares Outstanding

1.92M

Volume

1.91K

Avg. Volume

28.29K

Financials (TTM)

Gross Profit

$6.30M

Operating Income

-$30.12M

EBITDA

-$28.49M

Operating Cash Flow

-$34.51M

Capital Expenditure

-$72.00K

Free Cash Flow

-$34.58M

Cash & ST Invst.

$22.89M

Total Debt

$22.31M

Bolt Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$26.00K

-97.9%

Gross Profit

-$177.00K

-114.5%

Gross Margin

-6.81%

N/A

Market Cap

$8.21M

N/A

Market Cap/Employee

$157.98K

N/A

Employees

N/A

Net Income

-$7.24M

+34.4%

EBITDA

-$7.04M

+33.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$22.89M

-41.1%

Total Debt

$22.31M

-9.7%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$19.35M

-13.3%

Short Term Debt

$2.96M

+23.2%

Return on Assets

-61.59%

N/A

Return on Invested Capital

-74.03%

N/A

Free Cash Flow

-$8.02M

+40.0%

Operating Cash Flow

-$8.02M

+40.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CLRBCellectar Biosciences, Inc.

CLRBCellectar Biosciences, Inc.$2.60+3.17%

RNAZTransCode Therapeutics, Inc.

RNAZTransCode Therapeutics, Inc.$5.24+5.43%

IMNNImunon, Inc.

IMNNImunon, Inc.$1.80+0.56%

EVGNEvogene Ltd.

EVGNEvogene Ltd.$0.43+10.93%

INABIN8bio, Inc.

INABIN8bio, Inc.$1.43+5.15%

LYRALyra Therapeutics, Inc.

LYRALyra Therapeutics, Inc.$0.44-11.98%

MRKRMarker Therapeutics, Inc.

MRKRMarker Therapeutics, Inc.$1.46+11.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92+0.00%

NOKNokia

NOKNokia$13.03+0.00%

TAT&T

TAT&T$21.82-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.64+0.17%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.19+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.16-0.08%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.49-0.03%

Questions About BOLT

What is the current price of Bolt Biotherapeutics?

Bolt Biotherapeutics is trading at $3.95 per share.

What is the 52-week range for Bolt Biotherapeutics?

Over the past 52 weeks, Bolt Biotherapeutics has traded between $3.75 and $7.20.

How much debt does Bolt Biotherapeutics have?

As of the most recent reporting period, Bolt Biotherapeutics reported total debt of $22.31M.

How much cash does Bolt Biotherapeutics have on hand?

Bolt Biotherapeutics reported $11.81M in cash and cash equivalents in its most recent financial results.

What is Bolt Biotherapeutics’s dividend yield?

Bolt Biotherapeutics does not currently have a dividend yield.

Bolt Biotherapeutics

Bolt Biotherapeutics Financials at a Glance

BOLT News

Bolt Revenue Jumps 39 Percent in Q2

Why Bolt Biotherapeutics Stock Crashed Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bolt Biotherapeutics

BOLT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bolt Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BOLT

What is the current price of Bolt Biotherapeutics?

What is the 52-week range for Bolt Biotherapeutics?

How much debt does Bolt Biotherapeutics have?

How much cash does Bolt Biotherapeutics have on hand?

What is Bolt Biotherapeutics’s dividend yield?

Premium Investing Services